KEROS THERAPEUTICS INC
KEROS THERAPEUTICS INC logo
KROS

KEROS THERAPEUTICS INC (KROS)

$49.053.11%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$47.91
Day's Range
$49.855
$24.38
52-Week Range
$68.29
1 month return5.5%
3 month return34.45%
1 year return14.73%
5 year return7.6%

Company Information

Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematologic and musculoskeletal disorders with high unmet medical need. Keros is a leader in understanding the role of the Transforming Growth Factor-Beta family of proteins, which are master regulators of red blood cell and platelet production as well as of the growth, repair and maintenance of muscle and bone. Keros' lead protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes and in patients with myelofibrosis. Keros' lead small molecule product candidate, KER-047, is being developed for the treatment of anemia resulting from iron imbalance, as well as for the treatment of fibrodysplasia ossificans progressiva. Keros' third product candidate, KER-012, is being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension.
OrganizationKEROS THERAPEUTICS INC
Employees104
CEODr. Jasbir S. Seehra Ph.D.
IndustryCommercial Services

Analyst Recommendation

based on 4 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 4 Wall street analysts offering stock ratings for KEROS THERAPEUTICS INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 93.68%

Current

$49.05

Target

$95.0

Recommendation Trend

Based on 4 analyst

Current1M Ago3M Ago
Buy
4
10
10
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
1.3B
Book Value
$9.24
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.85
Wall Street Target Price
95.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
5.57
Enterprise Value
1.1B
Enterprise Value/Revenue
55.13
Enterprise Value/Ebitda
-13.91

Technicals

Beta
1.26
50 Day MA
43.62
200 Day MA
42.7

Institutional Holdings

FMR Inc

13.07%

Orbimed Advisors, LLC

6.1%

Alkeon Capital Management, LLC

4.39%

State Street Corporation

3.39%

Nantahala Capital Management, LLC

3.31%

Vanguard Group Inc

3.29%

Discover more

Frequently Asked Questions

What is KEROS THERAPEUTICS INC share price today?

Can Indians buy KEROS THERAPEUTICS INC shares?

How can I buy KEROS THERAPEUTICS INC shares from India?

Can Fractional shares of KEROS THERAPEUTICS INC be purchased?

What are the documents required to start investing in KEROS THERAPEUTICS INC stocks?

What are today’s High and Low prices of KEROS THERAPEUTICS INC?

What are today’s traded volumes of KEROS THERAPEUTICS INC?

What is today’s market capitalisation of KEROS THERAPEUTICS INC?

What is the 52 Week High and Low Range of KEROS THERAPEUTICS INC?

How much percentage KEROS THERAPEUTICS INC is down from its 52 Week High?

How much percentage KEROS THERAPEUTICS INC is up from its 52 Week low?

What are the historical returns of KEROS THERAPEUTICS INC?

Who is the Chief Executive Officer (CEO) of KEROS THERAPEUTICS INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*